The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.14BCNY
771.67M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue (TTM)
6.82BCNY
1.02B · vs all stocks (USD)
Updated Nov 19, 2026
Profit Margin
-52.53%
Updated Nov 19, 2026
Beta
0.7350x
vs all stocks
Updated Nov 19, 2026
52-Week Change
-39.49%
vs all stocks
Updated Nov 19, 2026
Market Capitalization
5.14BCNY
771.67M · vs all stocks (USD)
Updated Nov 19, 2026
Enterprise Value
33.86BCNY
5.08B · vs all stocks (USD)
Updated Nov 19, 2026
Forward P/E
5.71x
Updated Nov 19, 2026
Price to Sales (TTM)
0.7701x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.75×.Updated Nov 19, 2026
Price to Book (MRQ)
0.9547x
Updated Nov 19, 2026
Enterprise to Revenue
4.96x
Updated Nov 19, 2026
Enterprise to EBITDA
-89.67x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 15.25×.Updated Nov 19, 2026
Gross Margin
15.56%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 3.31%.Updated Nov 19, 2026
Profit Margin
-52.53%
Updated Nov 19, 2026
Operating Margin
-19.86%
Updated Nov 19, 2026
Return on Assets (TTM)
-1.39%
Updated Nov 19, 2026
Return on Equity (TTM)
-24.67%
Updated Nov 19, 2026
Revenue (TTM)
6.82BCNY
1.02B · vs all stocks (USD)
Updated Nov 19, 2026
Revenue per Share (TTM)
2.54CNYUpdated Nov 19, 2026
Quarterly Revenue Growth
-68.70%
Updated Nov 19, 2026
Gross Profit (TTM)
225.83MCNY
33.87M · vs all stocks (USD)
Updated Nov 19, 2026
EBITDA (TTM)
2.22BCNY
333.09M · vs all stocks (USD)
Updated Nov 19, 2026
Net Income (TTM)
-3.58BCNY
-537.43M · vs all stocks (USD)
Updated Nov 19, 2026
Quarterly Earnings Growth (YoY)
-58.34%
Updated Nov 19, 2026
Operating Cash Flow (TTM)
4.76BCNY
714.37M · vs all stocks (USD)
Updated Nov 19, 2026
Levered Free Cash Flow (TTM)
2.66BCNY
399.67M · vs all stocks (USD)
Updated Nov 19, 2026
5-Year Average Dividend Yield
1.75%
vs all stocks
Updated Nov 19, 2026
Payout Ratio
6166.67%
Updated Nov 19, 2026
Minority Interest (Equity)
7.10BCNYFY2025 · Dec 31, 2025
Revenue
13.06BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
10.34BCNYFY2025 · Dec 31, 2025
Gross Profit
2.72BCNYFY2025 · Dec 31, 2025
Operating Income
1.36BCNY
203.44M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-1.42BCNYFY2025 · Dec 31, 2025
Income Tax Expense
470.79MCNYFY2025 · Dec 31, 2025
Net Income
-1.89BCNYFY2025 · Dec 31, 2025
EBIT
-528.52MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
2.22BCNYFY2025 · Dec 31, 2025
Research & Development
74.23MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
298.88MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
439.08MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
72.10MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
895.40MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.7300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.7300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.70BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.70BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-1.89BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-75.27MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
6.95BCNYFY2025 · Dec 31, 2025
Free Cash Flow
5.51BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
7.56BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-1.89BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
929.82MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
1.45BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
6.47BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-1.44BCNYFY2025 · Dec 31, 2025
Net Acquisitions
454.98MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-154.03MCNYFY2025 · Dec 31, 2025
Sale of Investments
43.52MCNYFY2025 · Dec 31, 2025
Other Investing Activity
228.88MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-865.25MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
9.51BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-11.75BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-881.74MCNYFY2025 · Dec 31, 2025
Other Financing Charges
697.47MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-2.43BCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.71BSharesUpdated Nov 19, 2026
Float Shares
854.77MSharesUpdated Nov 19, 2026
% Held by Insiders
69.84%
vs all stocks
Updated Nov 19, 2026
% Held by Institutions
0.85%
vs all stocks
Updated Nov 19, 2026
Total Cash (MRQ)
7.58BCNY
1.14B · vs all stocks (USD)
Updated Nov 19, 2026
Total Cash per Share (MRQ)
2.80CNYUpdated Nov 19, 2026
Total Debt (MRQ)
28.40BCNY
4.26B · vs all stocks (USD)
Updated Nov 19, 2026
Total Debt to Equity (MRQ)
2.15x
Updated Nov 19, 2026
Current Ratio (MRQ)
1.45x
Updated Nov 19, 2026
Book Value per Share (MRQ)
2.03CNYUpdated Nov 19, 2026
Total Assets
59.89BCNY
8.98B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
25.27BCNYFY2025 · Dec 31, 2025
Total Liabilities
45.91BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
34.62BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
25.05BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
20.87BCNYFY2025 · Dec 31, 2025
Cash
3.21BCNYFY2025 · Dec 31, 2025
Cash Equivalents
4.42BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
7.63BCNYFY2025 · Dec 31, 2025
Accounts Receivable
603.12MCNYFY2025 · Dec 31, 2025
Inventory
12.20BCNYFY2025 · Dec 31, 2025
Accounts Payable
3.08BCNYFY2025 · Dec 31, 2025
Short-term Debt
7.84BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.77BCNYFY2025 · Dec 31, 2025
Long-term Debt
21.33BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.08BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.71BCNYFY2025 · Dec 31, 2025
Retained Earnings
1.54BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
13.98BCNY
2.10B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
0.00CNYFY2025 · Dec 31, 2025
52-Week Low
1.88CNYUpdated Nov 19, 2026
52-Week High
3.21CNYUpdated Nov 19, 2026
52-Week Change
-39.49%
vs all stocks
Updated Nov 19, 2026
Beta
0.7350x
vs all stocks
Updated Nov 19, 2026
50-Day MA
2.21CNYUpdated Nov 19, 2026
200-Day MA
2.31CNYUpdated Nov 19, 2026
Avg 10-Day Volume
20.73MSharesUpdated Nov 19, 2026
Avg 30-Day Volume
25.39MSharesUpdated Nov 19, 2026
Diluted EPS (TTM)
-1.32CNYUpdated Nov 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.38: distress zoneCritical
Altman Z-Score: 0.38
High earnings qualityNotable
Earnings Quality Score: 0.77
Supply Chain
Upstream position: supplies 7 industries, depends on 1Notable
Outgoing: 7.00Incoming: 1.00
Scale
Revenue is $1.02B, above the global median of $566.17MNotable